000167249 001__ 167249
000167249 005__ 20240229133534.0
000167249 0247_ $$2doi$$a10.1155/2021/8815297
000167249 0247_ $$2pmid$$apmid:33505716
000167249 0247_ $$2pmc$$apmc:PMC7815416
000167249 0247_ $$2ISSN$$a2090-0422
000167249 0247_ $$2ISSN$$a2090-0430
000167249 0247_ $$2altmetric$$aaltmetric:120415105
000167249 037__ $$aDKFZ-2021-00222
000167249 041__ $$aeng
000167249 082__ $$a610
000167249 1001_ $$aLi, Xinjun$$b0
000167249 245__ $$aFamilial Risks between Pernicious Anemia and Other Autoimmune Diseases in the Population of Sweden.
000167249 260__ $$aLondon [u.a.]$$bSage-Hindawi$$c2021
000167249 3367_ $$2DRIVER$$aarticle
000167249 3367_ $$2DataCite$$aOutput Types/Journal article
000167249 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1651060144_21834
000167249 3367_ $$2BibTeX$$aARTICLE
000167249 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000167249 3367_ $$00$$2EndNote$$aJournal Article
000167249 500__ $$a#LA:C050# /  2021 Jan 12;2021:8815297
000167249 520__ $$aPernicious anemia (PA) is an autoimmune disease (AID) which is caused by lack of vitamin B12 (cobalamin) due to its impaired uptake. PA is a multifactorial disease which is associated with a number of other AID comorbidities and which is manifested as part of autoimmune polyglandular syndrome. Due to the shortage of family studies on PA, we planned to address the problem by assessing familial risks for concordant PA between family members and for discordant PA in families of other AID patients.We collected data on patients diagnosed with AIDs from the Swedish hospitals and family data from a population register. We calculated standardized incidence ratios (SIRs) in families for concordant and discordant risks.The number of PA patients in the offspring generation (for which the familial risk was calculated) was 7701; 278 (3.6%) patients had a family history of PA. The population prevalence of PA was 0.9/1000. The familial risk for PA was 3.88 when any first-degree relative was the proband, equal for men and women. The familial risk was two times higher between siblings than between offspring and parents which may be due to complex genetic background. Associations of PA with 14 discordant AIDs were significant; these included some AIDs that have previously been described as comorbidities in PA patients and several yet unreported associations, including rheumatoid arthritis and other AIDs.The familial risks for PA were high suggesting multifactorial genetic etiology. The results call for further population-level studies to unravel mechanisms of familial PA which may help to understand the etiology of this disease.
000167249 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000167249 588__ $$aDataset connected to CrossRef, PubMed,
000167249 7001_ $$0P:(DE-He78)9af7dea9c075a972fcfa22b583471dae$$aThomsen, Hauke$$b1
000167249 7001_ $$aSundquist, Kristina$$b2
000167249 7001_ $$aSundquist, Jan$$b3
000167249 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b4$$udkfz
000167249 7001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b5$$eLast author$$udkfz
000167249 773__ $$0PERI:(DE-600)2573894-X$$a10.1155/2021/8815297$$gVol. 2021, p. 1 - 5$$p8815297$$tAutoimmune diseases$$v2021$$x2090-0430$$y2021
000167249 909CO $$ooai:inrepo02.dkfz.de:167249$$pVDB
000167249 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9af7dea9c075a972fcfa22b583471dae$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000167249 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000167249 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000167249 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000167249 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000167249 9141_ $$y2021
000167249 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-08-23
000167249 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-23
000167249 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-08-23
000167249 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000167249 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000167249 9201_ $$0I:(DE-He78)C050-20160331$$kC050$$lMolekular-Genetische Epidemiologie$$x2
000167249 980__ $$ajournal
000167249 980__ $$aVDB
000167249 980__ $$aI:(DE-He78)B062-20160331
000167249 980__ $$aI:(DE-He78)HD01-20160331
000167249 980__ $$aI:(DE-He78)C050-20160331
000167249 980__ $$aUNRESTRICTED